Coronary artery disease (CAD) clinical practice guidelines.

GUIDELINE TITLE
Coronary artery disease (CAD) clinical practice guidelines.

BIBLIOGRAPHIC SOURCE(S)
Kaiser Permanente Care Management Institute. Coronary artery disease (CAD) clinical practice guidelines. Oakland (CA): Kaiser Permanente Care Management Institute; 2008 May. 194 p. [137 references]

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: Kaiser Permanente Care Management Institute. Secondary prevention of coronary artery disease clinical practice guideline. Oakland (CA): Kaiser Permanente Care Management Institute; 2006 Mar. 117 p. [51 references]

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

November 17, 2009 - Plavix (clopidogrel): The U.S. Food and Drug Administration (FDA) notified healthcare professionals of new safety information concerning an interaction between clopidogrel (Plavix) and omeprazole (Prilosec/Prilosec OTC) used to reduce stomach acid. New data show that when clopidogrel and omeprazole are taken together, the effectiveness of clopidogrel is reduced.

open here to see the full-text:
Coronary artery disease (CAD) clinical practice guidelines.